位置:首页 > 蛋白库 > CDIA_YERMW
CDIA_YERMW
ID   CDIA_YERMW              Reviewed;        2963 AA.
AC   C4SGN7;
DT   08-MAY-2019, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 1.
DT   25-MAY-2022, entry version 55.
DE   RecName: Full=tRNA nuclease CdiA {ECO:0000303|PubMed:29923643};
DE            Short=tRNase CdiA {ECO:0000303|PubMed:29923643};
DE            EC=3.1.-.- {ECO:0000269|PubMed:29923643};
DE   AltName: Full=Contact-dependent inhibitor A {ECO:0000303|PubMed:29923643};
DE            Short=CdiA-43969 {ECO:0000303|PubMed:29923643};
DE   AltName: Full=Toxin CdiA;
DE   Flags: Precursor;
GN   Name=cdiA {ECO:0000303|PubMed:29923643}; ORFNames=ymoll0001_27200;
OS   Yersinia mollaretii (strain ATCC 43969 / DSM 18520 / CIP 103324 / CNY 7263
OS   / WAIP 204).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Yersiniaceae; Yersinia.
OX   NCBI_TaxID=349967;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43969 / DSM 18520 / CIP 103324 / CNY 7263 / WAIP 204;
RA   Read T.D., Akmal A., Bishop-Lilly K., Chen P.E., Cook C., Kiley M.P.,
RA   Lentz S., Mateczun A., Nagarajan N., Nolan N., Osborne B.I., Pop M.,
RA   Sozhamannan S., Stewart A.C., Sulakvelidze A., Thomason B., Willner K.,
RA   Zwick M.E.;
RT   "Annotation of the Yersinia mollaretii ATCC 43969 genome.";
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION.
RC   STRAIN=ATCC 43969 / DSM 18520 / CIP 103324 / CNY 7263 / WAIP 204;
RX   PubMed=29923643; DOI=10.1111/mmi.14007;
RA   Michalska K., Quan Nhan D., Willett J.L.E., Stols L.M., Eschenfeldt W.H.,
RA   Jones A.M., Nguyen J.Y., Koskiniemi S., Low D.A., Goulding C.W.,
RA   Joachimiak A., Hayes C.S.;
RT   "Functional plasticity of antibacterial EndoU toxins.";
RL   Mol. Microbiol. 109:509-527(2018).
CC   -!- FUNCTION: Toxic component of a toxin-immunity protein module, which
CC       functions as a cellular contact-dependent growth inhibition (CDI)
CC       system. CDI modules allow bacteria to communicate with and inhibit the
CC       growth of closely related neighboring bacteria in a contact-dependent
CC       fashion. Targeting of the CT domain (residues 2824-2963) in the absence
CC       of immunity protein inhibits cell growth and causes tRNA(UUC-Glu)
CC       cleavage in the anticodon loop; expression of cognate immunity protein
CC       CdiI-43969 neutralizes growth inhibition and tRNA(UUC-Glu) remains
CC       intact, whereas non-cognate immunity proteins do not confer protection
CC       from the toxic effects. {ECO:0000269|PubMed:29923643}.
CC   -!- FUNCTION: The CdiA protein is thought to be exported from the cell
CC       through the central lumen of CdiB, the other half of its two-partner
CC       system (TPS). The TPS domain probably remains associated with CdiB
CC       while the FHA-1 domain forms an extended filament with the receptor-
CC       binding domain (RBD) at its extremity; in the secretion arrested state
CC       the C-terminus of the RBD and YP domains form a hairpin-like structure
CC       as the FHA-2, PT and CT domains are periplasmic. The YP domain is
CC       probably responsible for this arrest at the point where it re-enters
CC       the host cell periplasm. Upon binding to a target cell outer membrane
CC       receptor a signal is transmitted to activate secretion. The filament
CC       elongates slightly, the rest of CdiA is secreted and the FHA-2 domain
CC       becomes stably associated with the target cell's outer membrane where
CC       it facilitates entry of the toxic CT domain into the target cell
CC       periplasm. From there the toxic CT domain is cleaved and gains access
CC       to the target cell cytoplasm via an inner membrane protein.
CC       {ECO:0000305}.
CC   -!- SUBUNIT: Forms a 1:1 complex with cognate immunity protein CdiI.
CC       {ECO:0000305|PubMed:29923643}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000255}. Target cell, target cell
CC       cytoplasm {ECO:0000305|PubMed:29923643}. Note=Secreted to the cell
CC       surface by CdiB, its two partner secretion pathway (TPS) partner.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the CdiA toxin
CC       family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the bacterial EndoU
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AALD02000043; EEQ09309.1; -; Genomic_DNA.
DR   RefSeq; WP_004876812.1; NZ_CP054043.1.
DR   SMR; C4SGN7; -.
DR   EnsemblBacteria; EEQ09309; EEQ09309; ymoll0001_27200.
DR   GeneID; 57919904; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   Gene3D; 2.160.20.10; -; 1.
DR   InterPro; IPR010069; CdiA_FHA1_rpt.
DR   InterPro; IPR029501; EndoU_bac.
DR   InterPro; IPR008619; Filamentous_hemagglutn_rpt.
DR   InterPro; IPR008638; Filamn_hemagglutn_N.
DR   InterPro; IPR025157; Hemagglutinin_rpt.
DR   InterPro; IPR012334; Pectin_lyas_fold.
DR   InterPro; IPR011050; Pectin_lyase_fold/virulence.
DR   InterPro; IPR006914; VENN_dom.
DR   Pfam; PF14436; EndoU_bacteria; 1.
DR   Pfam; PF05594; Fil_haemagg; 9.
DR   Pfam; PF13332; Fil_haemagg_2; 5.
DR   Pfam; PF05860; Haemagg_act; 1.
DR   Pfam; PF04829; PT-VENN; 1.
DR   SMART; SM00912; Haemagg_act; 1.
DR   SUPFAM; SSF51126; SSF51126; 1.
DR   TIGRFAMs; TIGR01901; adhes_NPXG; 1.
DR   TIGRFAMs; TIGR01731; fil_hemag_20aa; 7.
PE   3: Inferred from homology;
KW   Endonuclease; Hydrolase; Nuclease; Secreted; Signal; Target cell cytoplasm;
KW   Toxin; Virulence.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000255"
FT   CHAIN           30..2963
FT                   /note="tRNA nuclease CdiA"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000446870"
FT   REGION          35..320
FT                   /note="Two-partner system transport domain (TPS)"
FT                   /evidence="ECO:0000250|UniProtKB:Q3YL96"
FT   REGION          573..1074
FT                   /note="FHA-1"
FT                   /evidence="ECO:0000305"
FT   REGION          1075..1342
FT                   /note="Receptor binding domain (RBD)"
FT                   /evidence="ECO:0000250|UniProtKB:A0A1S4NYE3"
FT   REGION          1343..1528
FT                   /note="YP domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q3YL96"
FT   REGION          1529..1751
FT                   /note="Periplasmic FHA-1 repeat (pFR)"
FT                   /evidence="ECO:0000305"
FT   REGION          1759..1787
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1762..2314
FT                   /note="FHA-2"
FT                   /evidence="ECO:0000305"
FT   REGION          1992..2012
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2694..2963
FT                   /note="C-terminal effector domain (CT)"
FT                   /evidence="ECO:0000269|PubMed:29923643"
FT   MOTIF           2694..2697
FT                   /note="VEDN CT cleavage motif"
FT                   /evidence="ECO:0000305"
FT   COMPBIAS        1771..1787
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   2963 AA;  308750 MW;  43A14562136B6E59 CRC64;
     MIPIYLRQKL ISYALIYLVA IQPIMPVMAA GIDVAQGSTA LDKAGNGVPV VNIAPPNSAG
     VSHNVYNQFN VGSEGVILNN ATDRLTQTQL GGLIQSNANL NGKAAGAIIN EVVSANRSQL
     NGYLEVGGKA AAVMVANPYG ITCDGCGFIN TPNVTLTTGK PMMDTNGKLQ SLDVTQGAIS
     IQGKGLDASQ SSALSLISRA NEINAQIHAQ DLTVIAGSNR VDSAGHVSER QGQGDVPQVS
     IDTGALGGMY ANRIRLVSSE KGVGVNLGNL NARQGDIQLD SKGKLTVNNA VAHGDIIASA
     DQLHLQGHQR AQGNITLNSH GESRLDNATL LAGDTLAVKA GGKITSKESQ LNAGVDSAGN
     IGEKGTVSLQ GSELALQQSH VAAAAVSVVS SGDIVQDKES SLTARQLKLS GQHLELAGQL
     AANNDLSITG QSLRGSKTAS VGSQKNITFN LAGDSEWAGQ MVAGNDLIFS GQSLTNHGQL
     LAANQMHFEG LGLDNQGQIL AADINIAVHR LNNQGQLQGD KSLLLTADSL VQSTRGTMNS
     GRALTLRAAE MDISGDLQSQ ILDVKGDNWH NHGNVVAQEH AQLRLGHTID NRGVLVSAGD
     MDLSFNQLSN QGRILGAELA LSGKNISNSG QLVGKQQLSL QLDEGYQGTS SGELKSDGLL
     SVTADEINNQ GHWESGSLNT TAQQLTNNGK VLSVGSQNIN LSGSLTNQQL GQFLTDGEFI
     IVAEQVINSG LLQGNQAVTL NGLKQYQGGT GSQLLTKGVG EIHSDSVNNA GLIQAGSLSL
     TGEVLDNTGT LSGLSTLHID SHNEIINQAR GQLLSDNTIK LDSEQLVNNG LMQGTELVLA
     SQHLTNNGTL LGLTYLELQA VNLTNSSAGK ILSGQDLHFT TSHLQQNGQW TALRDLTGEI
     KGALDFSGAM AAGKQLSLQV DGDFNQRGNL QGNDVSITSR GVITNSGQLA AGSGSLALNG
     AAINQEQSGS LQSGGQISLT SRGDINNRGF VGAAGDLLLQ AIGAVNNTSL LYAGGSMRLL
     ADAIYNVRGD ILAGNHLWMQ RDNAGNSNRE IINSSGNIET QQGDMVLNTA SLLNRRDGFS
     VTEKTGAVNS GGIANVGATN ILISSGYFKP GEVTHYSKTV TGGGHHGNVS TVNLLGLVPS
     ARKQKLSTSS SIVTVDSPYD VGRIVAGRDI NISANTLVNQ ASQMSAGRNA LLQGQSLNNQ
     SYQSGTLTQY LVYTNTRDTN PEYNLFEFKL SGSPTYEISN DGQLYQGVIQ AVGSVSANFT
     QNLSNTSVKP NIGSIVHQVT QPSLTATTVP SELATKPNSG AAQVAPDSNN GDLVALYNQS
     GTALTFGLGT DGKPLTRAQL SDYPLPDSNN GLFVVNSEPG SRYLISTNPT LEKLGNVDST
     LLSGLQAMLG RQPQTSVAIE RNPQWTQQDN FLGSDYLLKK INLDAEHDYR FLGDAAFDTR
     YINNAVLSQT GQRYLNGVGS DLSQMQYLLD NAAQSQKKLD LKLGVSLTPE QVAQLSHSIV
     WWENINVNGQ TVLAPKLYLA KAEQAHLQGS VISGNKVELN AGSVTNSGVL KGVELLAIAS
     QDTITNEKGG LLTSEGALNL TALNNISNLS SSISGDRVAI TSQNGDIINQ TQTRQWSADQ
     SRQPGYWSGI KTQSMTQTEV GETAAITAGK ALTLAAGNNI AITGAKVTAA GDIGIQAAHD
     INIIANDLYS AQQQTLGRNR NIELNEQHES QSSHVSAGGT LTAHAGRDIT LSASHLGADG
     NATLQAERDV NLLVQEKSTR NQHIDSEDKT TGYTRSTLSS GGDLTASAGR DINSQAAAVT
     AENTLALNAG RDINLNAQES RQYNESHGKN YKRVDEAIRQ QGTELASGKG TQVHAGQDIN
     LHAASISAKG DLALQAGRDI AVNSATESDY HFFEEKKTKK KLVSKTTIHN VEEDFATTEK
     SSALVGNNVS LSAGNNLIVK GSSVVGDGTV VLKADNNVDI VAATEQQSSY RLNEKKTSGM
     FSGGGLGVTL GSKSSRQQIN QEGSKQSESA SAVGSTAGNV SILAGAQAHI SGSDVIAGKD
     LNVIAGTIKV DPGNDVLKRR QIYEQKQSGL TLSLSSPFTD ALLAINSKLK QASDAGSDKL
     SALYGAQAAR EAWVGVDGTM DMMASKPGGP AADPGASIKL QLSVGASHSK STSELAQNQT
     RGSSLTAGDN LTMVASGDHE QSGDLSVVGS GVTGNKVTLV AKNDVLLAAA SNNSEQTSRD
     SSSGWNAGVH LSLGKETGIG IAANGFMSKG NSDGKTTDYA NARINAKEAL AINSGRDTVL
     SGAQVLGDKI TAEIGRDLTI SSLQDSDNYN SIQKDASAGF SFTFGPSGGG SASFSLGKTK
     IESKYASVGD QSGFFAGSKG FDLNVGNHTQ LNGGVLASTA GAQDNLLSTG TLGWGDIHNQ
     AEYKATSTRI GYSTDAPMPT LGMANAHGSA SGTTRSAVAS GEIEIRNQGE QQQDVTTLSR
     DTDSANGRID KIFDESKVKD QMAFTQGVTQ LATQLVGDVS SWNMKQAERS AAEKLEKDPK
     YQNATREKRQ EMIYASADYK AAQESFGIGS SFWTAGMAVS AALTGLAGNA DIGSISSAAV
     APYLAGQIKK YTTDKDDKVN KTINILAHAI LGGIVAQMQG NSATAGALGG GGGELAARIY
     MDQVHPGKKV SDLSEADKKI VSAIGTLTAG ILGGLSTDSS TGLITGAQAG KNAVEDNNLS
     FGKGMADIGM SQTSLGVSML RNGTSPDEVS AALVKNSLGQ TPEGQDPIRG LLTAWAEFFG
     VPVTALIANG PMTVERAAEI VSSGVPTSEA KLIQYTAAKA FLAVAKNLPQ GTTLVSTPEG
     ISFRIDQPKH LSSVDGFTQK AGISGGHNAD AFYEAAKQYD VKILSETSTG AKGITEVKYQ
     IPTKDRAGNL TGGYKPAVET KTIYDPNVFT DQKILELGQQ AAAKGYKDAM ASKSGQASAT
     VDGVSFRIYV DKDTGRVRNF HPN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024